61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year.
EXCLUSIVE: Dave CEO Notes Mark Cuban Has Been On Co. Board For Last 5 Years, Has Been Urging Mgmt. To Engage With Crypto, CEO Says ‘This Is Just Not The Right Time For Us’
https://www.youtube.com/watch?v=itAA9oJ5k3g
EXCLUSIVE: Dave CEO Says Mgmt. Views Its Audience As 150M Americans Who Can’t Set Aside A Few Hundred Dollars For Emergencies
https://www.youtube.com/watch?v=itAA9oJ5k3g
EXCLUSIVE: Dave CEO Says ‘We Are So Early In Our Story From An Average Revenue Per User Perspective’
https://www.youtube.com/watch?v=itAA9oJ5k3g
EXCLUSIVE: Dave CEO Notes 2 Advantages Co. Has Over Big Banks: 1. Doesn’t Have Huge Compliance Teams, 2. Co.’s Data Structure Leads To Lower Costs
https://www.youtube.com/watch?v=itAA9oJ5k3g
EXCLUSIVE: Dave CEO Says Co.’s Mission Is To Create Financial Opportunity That Advances America’s Collective Potential
https://www.youtube.com/watch?v=itAA9oJ5k3g
CEO Of VPC Impact Acquisition Holdings III SPAC Merger Partner, Dave, Jason Wilk Begins Interview On Benzinga’s ‘SPACs Attack’ YouTube Show
https://www.youtube.com/watch?v=itAA9oJ5k3g
CEO Of VPC Impact Acquisition Holdings III SPAC Merger Partner, Dave, Jason Wilk Will Interview On Benzinga’s ‘SPACs Attack’ YouTube Show Wednesday At 11:15 a.m. EST
https://www.youtube.com/watch?v=itAA9oJ5k3g
VPC Impact Acquisition Holdings III Reports Entered Amendment To PIPE Deal With Alameda Research Ventures Related To Business Combo With Dave
VPC Impact Acquisition Holdings III, Inc. (NYSE:VPCC) (“VPCC”), a special purpose acquisition company sponsored by Victory Park Capital (“VPC”), today announced that it has entered into an